105884-19-3

Basic information

• Product Name: 5-Bromo-2-Chloroacetophenone
• Synonyms: 1-(5-Bromo-2-chlorophenyl)ethan-1-one;1-(5-Bromo-2-chlorophenyl)
• CAS NO: 105884-19-3
• Molecular Formula: C₈H₆BrClO
• Molecular Weight: 233.491
• Product Categories: Aromatic Acetophenones & Derivatives (substituted)
• Mol File: 105884-19-3.mol

Chemical Properties

• Boiling Point: 260℃
• Flash Point: 111℃
• Appearance: /
• Density: 1.566
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 5-Bromo-2-Chloroacetophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-Chloroacetophenone(105884-19-3)
• EPA Substance Registry System: 5-Bromo-2-Chloroacetophenone(105884-19-3)

Safety Data

• Hazardous Substances Data: 105884-19-3(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
5-Bromo-2-Chloroacetophenone is used as a starting material for the synthesis of other organic compounds. Its unique functional groups allow for various chemical reactions, making it a valuable component in the production of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Bromo-2-Chloroacetophenone is used as an intermediate in the synthesis of various drugs. Its reactivity and functional groups enable the development of new drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
5-Bromo-2-Chloroacetophenone is also utilized in the agrochemical industry for the synthesis of pesticides and other crop protection agents. Its chemical properties allow for the creation of effective compounds that can protect crops from pests and diseases.
Safety Precautions:
It is important to handle 5-Bromo-2-Chloroacetophenone with care, as it can cause skin and eye irritation. Additionally, it may be harmful if inhaled or swallowed. Proper safety measures, as outlined in material safety data sheets, should be followed during its use and storage to minimize potential health risks.

InChI:InChI=1S/C8H6BrClO/c1-5(11)7-4-6(9)2-3-8(7)10/h2-4H,1H3

Upstream product

• 842136-59-8 5-bromo-2-chloro-N-methoxy-N-methyl-benzamide 
• 75-16-1 methylmagnesium bromide 
• 21739-92-4 5-bromo-2-chlorobenzoic acid 
• 749932-77-2 1-(5-bromo-2-chlorophenyl)ethan-1-ol 

Downstream Products

• 289039-22-1 4-bromo-1-chloro-2-ethyl-benzene 
• 749932-77-2 1-(5-bromo-2-chlorophenyl)ethan-1-ol 
• 945717-56-6 4-bromo-1-chloro-2-(prop-1-en-2-yl)benzene 
• 1616929-85-1 5-(2-chloro-5-thiazol-2-yl-phenyl)-N-(2,6-difluoro-phenyl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1616929-84-0 5-(2-chloro-5-thiazol-2-yl-phenyl)-N-(3-fluoro-pyridin-4-yl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1616930-39-2 C₁₄H₁₀ClN₃O₂S 
• 1616930-38-1 C₁₆H₁₄ClN₃O₂S 
• 1616930-37-0 C₁₃H₁₂BrClN₂O₂ 
• 1616930-36-9 C₁₂H₁₀BrClO₄ 
• 1203604-92-5 5-(2-Chloro-5-pyridin-3-ylphenyl)-N-[(5-methoxy-1,3-benzothiazol-2-yl)methyl]-1,2,4-triazin-3-amine 
• 1203604-90-3 C₂₁H₁₆ClN₇OS 
• 1203604-88-9 N-[4-chloro-3-(3-{[(5-methoxy-1,3-benzothiazol-2-yl)methyl]amino}-1,2,4-triazin-5-yl)phenyl]acetamide 
• 1203604-94-7 5-(2-chlorophenyl)-N-[(5-methoxy-1,3-benzothiazol-2-yl)methyl]-1,2,4-triazin-3-amine 
• 1203604-07-2 5-(5-bromo-2-chlorophenyl)-N-[(5-methoxy-1,3-benzothiazol-2-yl)methyl]-1,2,4-triazin-3-amine 

Relevant articles and documents

SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS

The present invention relates to substituted alkynylene compounds represented by compound of formula (I) pharmaceutically acceptable salts and stereoisomers thereof. The present invention further provides the methods of preparation of compound of formula (I) and therapeutic uses thereof as anti-cancer agents.

NOVEL FUSED IMIDAZOLE DERIVATIVE

The present invention relates to a compound represented by the Formula [I]: Wherein: the A ring is a 5-membered aromatic heterocyclic group containing at least one hetero atom selected from a nitrogen atom, and the like; A1 and A2, are each a nitrogen atom, and the like; X2, X3, X4, and X5 are all carbon atoms, or alternatively any one of X2, X3, X4, and X5 is a nitrogen atom and the rest are all carbon atoms; R1 is a hydrogen atom, or the like; R2, R3, R4, and R5, are each a hydrogen atom, or the like; R6 and R6', are each a hydrogen atom, and the like; R7 is an aryl group and the like; and R8 is an amino group or a hydroxy group, or a pharmaceutically acceptable salt or ester thereof.

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).